Skip to content

IDEAYA Biosciences, Inc. IDYA Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Tango Therapeutics logo
Tango TherapeuticsTNGX
$33.57M
Erasca, Inc. logo
Erasca, Inc.ERAS
$45.95M-9.6%
Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Nuvation Bio logo
Nuvation BioNUVB
$4.04M-29.5%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.42M-42.5%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$20.89M+189%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s operating lease liabilities (total)?
IDEAYA Biosciences, Inc. (IDYA) reported operating lease liabilities (total) of $28.6M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s operating lease liabilities (total) changed year-over-year?
IDEAYA Biosciences, Inc.'s operating lease liabilities (total) increased by 10.1% year-over-year, from $25.97M to $28.6M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s operating lease liabilities (total)?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s operating lease liabilities (total) has grown at a 32.9% compound annual growth rate (CAGR), from $6.72M to $27.91M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.